So, pot may not be as harmless as a recent study suggested

adb-150

Researchers are correcting a widely covered study that suggested chronic use of pot might not put users at risk of problems later in life.

It turns out that initial, unexpected finding — covered by Newsweek, The Washington Post, Quartzand (of course) The Stoner’s Cookbook (now known as HERB) wasn’t quite right, and a reanalysis found users had a small uptick in risk for psychosis. The authors have issued a lengthy correction in Psychology of Addictive Behaviors that includes some supplemental analysis, too.

Not surprisingly, the study’s findings engendered some controversy, which prompted the authors to reanalyze their data, collected from 408 males with varying levels of marijuana use, who were followed from their teens into their 30s.

Now, an American Psychological Association press release that accompanied the initial findings in August contains an editors note explaining why those aren’t quite correct:

Continue reading So, pot may not be as harmless as a recent study suggested

Here are the 10 — yes, 10 — reasons PLOS ONE retracted this paper

Screen Shot 2016-01-19 at 10.50.25 AMPLOS One is retracting a paper for overlapping with a Wikipedia page. And for containing material lifted from other sources. And for “language errors.” And for insufficient evidence that authors found the pathogens floating around in hospital air that they claimed to find.

The instances of plagiarism are a “huge problem,” each “enough for retraction on its own,” Jonathan Eisen, a microbiologist at the University of California, Davis, told us. Eisen, who posted several comments to the paper after its publication in October, added that the paper was “simply not technically sound.”

The paper — which even contains a spelling error in its title, “Metagenomic Human Repiratory Air in a Hospital Environment” — describes a gene sequencing method to screen the air in hospitals for pathogens. The retraction note lists 10 concerns with the paper: Continue reading Here are the 10 — yes, 10 — reasons PLOS ONE retracted this paper

Paper on pine tree genetics chopped for duplication

naslovna_vol6_no2A paper on genetic variability in Austrian pine trees apparently didn’t vary enough from other work.

The journal is now retracting the 2012 paper for having significant overlap with another paper published in 2008. Another researcher pointed out the duplication — which was unintentional, according to the note, the result of

an apparent failure in communication between the co-authors on both papers which caused the papers to be overlapped.

The overlapping papers share a first author, Aleksandar Lucic, who works at the Institute of Forestry in Serbia. The other author on both papers is Vasilije Isajev, at the Faculty of Forestry in Belgrade.

Analysis of Genetic Variability of Austrian Pine (Pinus nigra Arnold) in Serbia Using Protein Markers” was published in South-East European Forestry. The journal is not indexed on Thomson Scientific’s Web of Knowledge.

Here’s the retraction note:

Continue reading Paper on pine tree genetics chopped for duplication

Oops! Authors accidentally include extra patients in biopsy paper

Screen Shot 2015-12-30 at 2.06.59 PM

A paper that compared two gauges of needles to take samples of pancreatic masses has been retracted after authors unintentionally included patients from another trial.

Randomized Trial Comparing the Flexible 19G and 25G Needles for Endoscopic Ultrasound-Guided Fine Needle Aspiration of Solid Pancreatic Mass Lesions,” published a year ago in Pancreas, notes that:

A total of 100 patients with solid pancreatic mass lesions constituted the study cohort and were randomized equally to the 2 needle groups.

The problem? According to the retraction note, some of those patients weren’t supposed to be included:

Continue reading Oops! Authors accidentally include extra patients in biopsy paper

Cancer Cell paper under investigation following anonymous queries on PubPeer

cancer cell

A Cancer Cell paper that caused a flurry of activity on the website PubPeer is under investigation, after the last author announced on the site that he’d requested a correction from the journal.

The 2012 paper sparked a lively dialogue last month on the post-publication discussion site, as commenters questioned Western blot images in which some bands appeared to be duplicates. The last author responded, noting he had alerted the journal to a “mishap,” and a correction would be forthcoming. However, some commenters remained unsatisfied, and questioned why the correction was taking so long to appear, as well as the explanation for what went wrong.

A spokesman from Cancer Cell confirmed to us the paper is under investigation:

Continue reading Cancer Cell paper under investigation following anonymous queries on PubPeer

Science retracting paper by chemists cut off from NSF funding

Bruce Eaton
Bruce Eaton

feldheim
Daniel Feldheim

The National Science Foundation will no longer fund a pair of chemists who “recklessly falsified data,” according to a report from the NSF’s Office of Inspector General, unless they “take specific actions to address issues” in a 2004 Science paper.

That paper is going to be retracted as soon as possible, Science told us. The co-authors that the NSF reprimanded are Bruce Eaton and Dan Feldheim, now at the University of Colorado at Boulder; they have been under scrutiny since 2008, when an investigation at North Carolina State University, their former employer, found that the Science paper contained falsified data.

The paper, “RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles,” has been cited 138 times.

Science Editor in Chief  Marcia McNutt told us today that a retraction is in the works:

Continue reading Science retracting paper by chemists cut off from NSF funding

Misidentified DNA leads authors to retract zebrafish cholesterol paper

cov150h

Authors are retracting a 2012 paper on cholesterol metabolism in zebrafish after realizing it included a case of mistaken identity in a DNA sequence crucial to some aspects of the experiment.  

A postdoc misidentified the plasmid in question after failing to fully sequence it before including it in the experiment. A technician in the lab found the mistake, last author Steven Farber, a researcher at the Carnegie Institution for Science in Maryland, explained:

When the omitted region was correctly sequenced we discovered it had an error.

He told us in a phone interview what that felt like:

We were like, holy crap.

Next came months of back and forth with the journal, discussing whether to correct or retract the paper. Farber tells us the mistake, which affects two figures,

was unfortunate. Most of the paper is in fact correct.

The paper, “Visualization of Lipid Metabolism in the Zebrafish Intestine Reveals a Relationship between NPC1L1-Mediated Cholesterol Uptake and Dietary Fatty Acid,” published in Chemistry & Biology, has been cited 21 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the detailed retraction noteContinue reading Misidentified DNA leads authors to retract zebrafish cholesterol paper

Voinnet’s notice count grows, as he notches his 18th correction

home_coverOlivier Voinnet, a high-profile plant scientist at ETH Zurich, has earned a mega-correction. It wrapped up a rough year for the biologist, which included his seventh retraction, and a CNRS investigation that found evidence of misconduct.

This latest correction, to a paper on the mechanisms behind RNA silencing in Arabidopsis, was published in RNA. The 2007 paper has been cited 101 times, according to Thomson Scientific’s Web of Knowledge. The corrigendum modifies three figures in total.

The notice is long, so we’re not going to post the whole thing here. The first error in “Transitivity in Arabidopsis can be primed, requires the redundant action of the antiviral Dicer-like 4 and Dicer-like 2, and is compromised by viral-encoded suppressor proteins” is a clarification to a legend:

Continue reading Voinnet’s notice count grows, as he notches his 18th correction

Retraction published for nutrition researcher Marion Nestle

journal_pubhealthFollowing her request last month, a public health journal has retracted a paper co-authored by prominent nutrition researcher Marion Nestle, after revelations of multiple factual errors and her co-author’s ties to one of the subjects of the article.

The article, an opinion piece, critiqued the supposed relationship between the biggest beverage distributor in Guatemala and the leading Guatemala-based public health organization, to distribute a fortified supplement (Manì+) for undernourished children. The relationship, the piece argued, raised concerns about the conflicts of interest that can occur when a food company pairs with a public health organization. But soon after publication, Nestle learned that she and her co-author Joaquin Barnoya had misrepresented that relationship, and failed to disclose that the public health organization was paying a portion of Barnoya’s salary.

Here’s the full retraction notice, published earlier this month by the Journal of Public Health Policy: Continue reading Retraction published for nutrition researcher Marion Nestle

Neuroscience paper retracted after colleagues object to data publication

frontiersA paper published this October in the journal Frontiers In Neuroscience was retracted the following month because the authors’ collaborators did not give them permission to publish some of the data.

The paper detailed how and why the authors use the software program Nengo to test large simulations of nervous system networks. As part of the research, the authors tested five systems, one of which they were working on with another group. Due to a “miscommunication,” the authors thought they had received permission to publish the data; they plan to resubmit a paper describing the other four systems.

Here’s the official retraction note: Continue reading Neuroscience paper retracted after colleagues object to data publication